Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer

[11] Sylvester R(2019)A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens BJU Int 123 11-21

[12] Pisano F(2018)Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder World J Urol 36 231-240

[13] Fernandez-Gomez J(2015)Gender differences in incidence and outcomes of urothelial and kidney cancer Nat Rev Urol 12 585-592

[14] Madero R(2016)Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes Eur Urol 69 300-310

[15] Solsona E(2012)Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette–Guérin Eur Urol 62 118-125

[16] Cambier S(2013)Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder World J Urol 31 1029-1036

[17] Sylvester RJ(2016)Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the international bladder cancer group J Clin Oncol 34 1935-1944

[18] Collette L(2009)Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder Eur Urol 56 1093-1095

[19] Hurst CD(2019)Sex-specific differences in the quality of treatment of muscle-invasive bladder cancer do not explain the overall survival discrepancy Eur Urol Focus 2 127-137

[20] Alder O(2016)Effects of androgen and estrogen receptor signaling pathways on bladder cancer initiation and progression Bladder Cancer 3 622-630

[11] Sylvester R(2019)A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens BJU Int 123 11-21

[12] Pisano F(2018)Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder World J Urol 36 231-240

[13] Fernandez-Gomez J(2015)Gender differences in incidence and outcomes of urothelial and kidney cancer Nat Rev Urol 12 585-592

[14] Madero R(2016)Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes Eur Urol 69 300-310

[15] Solsona E(2012)Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette–Guérin Eur Urol 62 118-125

[16] Cambier S(2013)Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder World J Urol 31 1029-1036

[17] Sylvester RJ(2016)Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the international bladder cancer group J Clin Oncol 34 1935-1944

[18] Collette L(2009)Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder Eur Urol 56 1093-1095

[19] Hurst CD(2019)Sex-specific differences in the quality of treatment of muscle-invasive bladder cancer do not explain the overall survival discrepancy Eur Urol Focus 2 127-137

[20] Alder O(2016)Effects of androgen and estrogen receptor signaling pathways on bladder cancer initiation and progression Bladder Cancer 3 622-630